Eagle Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
1,097
-351
-24% -$359K 1% 24
2026
Q1
$1.33M Sell
1,448
-808
-36% -$819K 1.23% 17
2025
Q4
$2.42M Buy
+2,256
New +$2.16M 2.07% 13

Other funds holding LLY

Eagle Wealth Advisors's LLY Position: Q2 2026 in Review

Eagle Wealth Advisors reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $359K and leaving 1,097 shares worth $1.32M. The position accounts for 1% of the portfolio, ranked #24.

Eagle Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.42M in Q4 2025. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Eagle Wealth Advisors held 1,097 shares of Eli Lilly worth $1.32M as of Q2 2026.
  • Eagle Wealth Advisors sold 351 Eli Lilly shares in Q2 2026, an estimated $359K.
  • Eli Lilly made up 1% of Eagle Wealth Advisors's portfolio in Q2 2026, its #24 holding.
  • Eagle Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Eagle Wealth Advisors's Eli Lilly position peaked at $2.42M in Q4 2025.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eagle Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.